CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study

The relationship between cytochrome P450 2C19 (CYP2C19) polymorphisms and clopidogrel efficacy in patients with percutaneous coronary intervention (PCI) has been widely studied. However, the relationship between CYP2C19 polymorphisms and the response to clopidogrel in patients treated for ischemic s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of palliative medicine 2021-12, Vol.10 (12), p.12171-12180
Hauptverfasser:	Lin, Juanna, Mo, You, Cai, De, Mao, Dongyang, Fu, Hongbo, Wei, Duncan
Format:	Artikel
Sprache:	eng
Schlagworte:	Clopidogrel - therapeutic use Cytochrome P-450 CYP2C19 - genetics Humans Ischemic Stroke - drug therapy Ischemic Stroke - prevention & control Platelet Aggregation Inhibitors - therapeutic use Secondary Prevention Ticlopidine - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!